Riskpilot← Back to searchSign inGet full accessC.L. INVEST AS
ASActiveOrg 927425564Youngstorget 2B, 0181 OsloEconomic activity was not specified by tax authority · NACE 0000Est. 202112 employees
Revenue 2024
NOK 0
EBITDA margin
—
-103% vs 2023
Equity ratio
43.2%
Financial strength
Net profit 2024
NOK 1,1M
+31% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -30K | -103% |
| Net profit | NOK 1,1M | +31% |
| Total assets | NOK 6,1M | +7% |
| Equity | NOK 2,7M | +75% |
| Employees | 12 | — |
Legal name
C.L. INVEST AS
Org number
927425564
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
15. juli 2021
Share capital
NOK 30 000
Employees
12 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investering i selskaper, eiendom, aksjer og verdipapir samt alt som står i forbindelse med dette, inkludert rådgivning.
Address
Youngstorget 2B, 0181 Oslo
Phone
+4722332528
Email
post@hudklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 17 134 | 19 748 | 7 323 | 0 |
| Staff expenses | −6 036 | −5 037 | −1 882 | −0 |
| EBITDA | 2 190 | 1 671 | 1 117 | −30 |
| Depreciation & amort. | −6 | −17 | −0 | −0 |
| EBIT | 2 184 | 1 654 | 1 117 | −30 |
| Net financials | −5 | −2 | −2 | 1 170 |
| Profit before tax | 2 179 | 1 652 | 1 115 | 1 140 |
| Tax | 467 | 359 | 245 | 4 |
| Net profit | 1 711 | 1 293 | 870 | 1 136 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 3 752 | 4 009 | 5 749 | 6 144 |
| Equity | 870 | 2 164 | 1 518 | 2 654 |
| Long-term debt | 0 | 0 | 0 | 4 |
| Short-term debt | 2 882 | 1 845 | 4 231 | 3 486 |
| Total debt | 2 882 | 1 845 | 4 231 | 3 490 |
EBITDA margin
-2966500.0%
This company
15.8%
Market median
-18775416% vs market
20212024
Equity ratio
43.2%
This company
38.2%
Market median
+13% vs market
20212024
Return on equity
42.8%
This company
18.4%
Market median
+133% vs market
20212024
Net profit margin
113570300.0%
This company
8.1%
Market median
+1402102369% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
1.31×
This company
0.62×
Market median
-111% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
JL Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2024 | |
| Former (1) | ||
| Chairman | 2023 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
C.L. INVEST AS 
HUDKLINIKKEN ASBoard members of C.L. INVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jon Langeland | Chief Executive Officer | 0 companies |
| Henrik Søyland Langeland | Chairman | 0 companies |
| Caroline Søyland Langeland | Chairman | 0 companies |